CADENCE CAPITAL MANAGEMENT LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$621,000
-11.5%
10,635
-20.0%
0.04%
-15.7%
Q3 2016$702,000
-77.9%
13,290
-53.5%
0.05%
-71.2%
Q2 2015$3,176,000
+9.7%
28,580
-6.9%
0.18%0.0%
Q1 2015$2,895,000
-33.8%
30,700
-21.3%
0.18%
-30.3%
Q4 2014$4,372,000
+1444.9%
39,020
+744.6%
0.25%
+1593.3%
Q3 2014$283,0004,6200.02%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Eagle Health Investments LP 354,650$18,314,0007.19%
Casdin Capital, LLC 2,165,000$111,801,0003.33%
Rock Springs Capital Management LP 2,543,600$131,352,0002.87%
HealthCor Management, L.P. 1,532,960$79,162,0002.80%
Bellevue Group AG 4,537,092$234,295,0002.48%
Woodline Partners LP 824,097$42,556,0000.94%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,081,347$55,841,0000.83%
Integral Health Asset Management, LLC 43,000$2,221,0000.64%
ArrowMark Colorado Holdings LLC 1,119,566$57,814,0000.43%
Virtus ETF Advisers LLC 18,328$946,0000.40%
View complete list of AGIOS PHARMACEUTICALS INC shareholders